Diagnosis: Acute Uncomplicated Cystitis (Urinary Tract Infection)
This 19-year-old female has a urinary tract infection requiring antibiotic treatment based on the presence of pyuria (protein 3+ likely representing WBCs), leukocyte esterase, bacteria, and WBCs in her urine. 1
Diagnostic Interpretation
The urinalysis findings confirm UTI through multiple converging indicators:
- Leukocyte esterase (trace) combined with microscopic WBCs indicates pyuria, which is the hallmark of true UTI and distinguishes infection from asymptomatic bacteriuria 1
- Bacteria present on microscopy in a fresh specimen correlates with significant bacteriuria (≥10⁵ CFU/mL) 1
- Protein 3+ in this context likely represents pyuria (≥10 WBCs/high-power field), as the presence of leukocytes combined with urinary symptoms strongly suggests UTI 1
- Hyaline casts indicate some degree of renal involvement, though this alone doesn't necessarily indicate pyelonephritis 1
Critical caveat: The presence of squamous epithelial cells suggests possible specimen contamination 1. However, given the constellation of other findings (leukocyte esterase, WBCs, bacteria), this represents a true infection rather than pure contamination 1.
The trace ketones are likely incidental, possibly from decreased oral intake due to dysuria or mild dehydration 1.
Treatment Algorithm
Step 1: Obtain Urine Culture Before Starting Antibiotics
Collect a properly obtained urine specimen for culture and antimicrobial susceptibility testing immediately 1. This is essential in a young woman to:
- Guide definitive therapy if symptoms persist 1
- Document the causative organism 1
- Identify resistance patterns for future episodes 1
Step 2: Initiate Empiric Antibiotic Therapy
First-line treatment options (choose one):
Nitrofurantoin 100 mg orally twice daily for 5-7 days (preferred first-line) 1
Fosfomycin 3 grams orally as a single dose 1
Trimethoprim-sulfamethoxazole 160/800 mg orally twice daily for 3 days 1, 2
Avoid fluoroquinolones (ciprofloxacin, levofloxacin) as first-line therapy—reserve as second-line options 1
Step 3: Assess for Complicated Features
This patient requires 7-14 days of therapy (NOT 3-5 days) if any of the following are present:
- Fever >37.8°C (101°F) suggesting pyelonephritis 1
- Flank pain or costovertebral angle tenderness 1
- Rigors or hemodynamic instability 1
- Systemic symptoms beyond dysuria/frequency 1
The presence of hyaline casts warrants careful assessment for upper tract involvement 1. If she has fever or flank pain, treat as pyelonephritis with 7-14 days of therapy 1.
Step 4: Clinical Reassessment
Reassess clinical response within 48-72 hours 1:
- If symptoms persist or worsen, consider imaging (renal/bladder ultrasound) to rule out obstruction or complicating factors 1
- Adjust antibiotics based on culture and susceptibility results 1
- No routine follow-up culture is needed if symptoms resolve completely 1
Common Pitfalls to Avoid
Don't dismiss the squamous epithelial cells as pure contamination when other findings clearly indicate infection—the combination of leukocyte esterase, WBCs, and bacteria confirms true UTI despite some contamination 1
Don't delay culture collection—always obtain culture before antibiotics in cases with significant pyuria 1
Don't undertreat if upper tract involvement is present—hyaline casts may indicate kidney involvement requiring longer therapy 1
Don't use fluoroquinolones as first-line therapy in uncomplicated cystitis—reserve for complicated infections or treatment failures 1
Don't assume 3-day therapy is sufficient if any features suggest pyelonephritis (fever, flank pain, systemic symptoms) 1
Special Considerations for Young Women
- E. coli remains the predominant pathogen (80-90% of uncomplicated UTI), followed by Klebsiella and Proteus species 3
- Three-day antimicrobial treatment is recommended for simple cystitis in the absence of complicating features 3
- Consider antimicrobial prophylaxis if she develops recurrent UTIs (≥2 infections in 6 months or ≥3 in 12 months) 3
- Document each episode with culture if recurrent infections occur to guide targeted therapy 1